Stock in Gland Pharma soars 5% after the US FDA makes no adverse findings Kumar Jeetendra | July 31, 2023 After receiving a zero-observation certificate from the US drug agency for its Visakhapatnam facility, Gland Pharma’s share price increased by 5.49 percent, closing at Rs 1,365 at 9:23am on July 31. Between July 20 and July 28, the United States Food and Drug Administration (US FDA) inspected the company’s VSEZ Sterile Oncology plant in Visakhapatnam …
